EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Adverum Biotechnologies, Inc. (ADVM) EBIT Margin data is not available for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-47.65M |
|
-- |
|
-- |
|
$48.02M |
|
$-48.02M |
|
$0.37M |
|
$-47.65M |
|
$-47.65M |
|
$-47.65M |
|
$-47.65M |
|
$-47.65M |
|
$-47.65M |
|
$-48.02M |
|
$-47.57M |
|
23.49M |
|
23.49M |
|
$-2.03 |
|
$-2.03 |
|
| Balance Sheet Financials | |
$28.91M |
|
$10.46M |
|
$43.49M |
|
$72.40M |
|
$44.75M |
|
-- |
|
$83.31M |
|
$128.05M |
|
$-55.65M |
|
$-55.65M |
|
$-55.65M |
|
22.00M |
|
| Cash Flow Statement Financials | |
$-109.65M |
|
$65.04M |
|
$10.02M |
|
$62.63M |
|
$28.04M |
|
$-34.59M |
|
$7.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.65 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
EBIT Margin |
-- |
-- |
|
-- |
|
-- |
|
$-110.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
85.62% |
|
85.62% |
|
-65.82% |
|
85.62% |
|
$-2.53 |
|
$-4.69 |
|
$-4.67 |
|